1Xue M, Del Bigio MR. lntracerebral injection of autologous whole blood in rats: time course of inflammation and cell death [J]. Neurosci Lett, 2010, 283(283): 230-235.
2Andrzej W, Marcin A, Jerzy C. Adiponectin-an adipokine with unique metabolic properties [J], Nephrol Dial Transplant, 2007, 22 (22): 981-983.
3Harris OA, Colford MJ, Good MC, et al. The role of hypothermia in the management of severe brain injury [J]. Archneurol, 2008,59(7): 1077-1088.
4Bobbert P, Rauch U, Stratmann B, et al. High molecular weight adiponectin correlates .positively with myeloperoxidase in patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2008, 82(2): 179-184.
5Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis [J]. JAMA, 2009, 302(2): 179-188.
6Heidemarm C, Sun Q, van Dam RM, et al. Total and high-molecu- lar-weight adiponectin and resistin in relation to the risk for type 2 di- abetes in women[J]. Ann Intern Med, 2008, 149(5): 307-316.
7Guzik T J, Mangalat D, Korbut R. Adipocytokines-novel link between inflammation and vascular function [J]. J Physiology pharmacology, 2006, 57(4): 505-528.
8Lu Qi, Alessandro Doria, Joann E Manson, et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes [J]. Diabetes, 2006,55(5): 1512-1516.
9Sung KC, Suh JY, Kim BS, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension [J]. Am J Hy- pertens, 2003, 16(6): 429-433.
10Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk fac- tor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force[J]. Ann Intern Med, 2009, 151 (7): 483-495.
